This site is intended for U.S. Healthcare Professionals.

ONUREG® is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Request a Rep

RESOURCES

Resources for healthcare providers

Be sure to bookmark or return to this page to remember these helpful resources.

Prescribing Information

Click here

How to order and access ONUREG®

Click here

Dosing guide

Click here

Meet 2 types of patients you may see in your practice

Click here

Resources for patients and caregivers

Be sure to bookmark or return to this page to remember these helpful resources.

Patient information

Click here

ONUREG.com patient website

Click here

ONUREG® patient brochure

Click here

ONUREG® Spanish patient brochure

Click here

ONUREG® patient wallet cards

Click here

Caregiver brochure

Click here